Irvine, California (ots/PRNewswire) - IsoTis, Inc. (NASDAQ: ISOT), the orthobiologics company, today announced it has completed the transfer of the rights associated with its PolyActive technology to OctoPlus (Euronext: OCTO), a drug delivery and development company, in exchange for an up-front payment of approximately $1.7 million and future royalty payments on sales of pharmaceutical products based on the ...
ÉVRY, France, April 23 (ots/PRNewswire) - April 30 - May 11, 2007 Epigenomics Project, Genopole(R), ÉVRY, France (near Paris) ÉVRY, France, April 23 /PRNewswire/ -- Genopole(R) and the Epigenomics Project organise a two-week school on biological complexity and modeling in the ...
Basel, Switzerland (ots/PRNewswire) - - Findings Illustrate Role of Innovative New Treatment in Population Most Affected by Chronic Kidney Disease A new Roche Phase III analysis shows once-monthly MIRCERA, a continuous erythropoietin receptor activator, effectively treats renal anaemia in one of the ...
Toronto, Canada (ots/PRNewswire) - - Vasogen to Host Conference Call Today at 9:00 a.m. (ET) Vasogen Inc. (NASDAQ:VSGND; TSX:VAS) today announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), a leading European pharmaceutical and medical devices company, to commercialize Vasogen's Celacade(TM) technology for the treatment of chronic ...
Los Angeles (ots/PRNewswire) - - Awards Presented for Substantial Contributions to Cancer Research Innovative and collaborative cancer research can be the catalyst to improving patient outcomes. Celebrating the 100th anniversary of the American Association for Cancer Research (AACR) at the 2007 AACR Annual Meeting in Los Angeles, Eli Lilly and Company in ...
Irvine, California (ots/PRNewswire) - In the news release, "IsoTis Appoints James P. Abraham as Senior Vice President Sales" issued on 16 Apr 2007 12:00 GMT, by Isotis Inc nasdaq:ISOT over PR Newswire, we are advised by a representative of the company that the release is the same for several wire tasks, so the destinations will be added to this task transmitted by PR Newswire. Complete, corrected release follows: ...
Basel, Switzerland (ots/PRNewswire) - Nephrologists attending the upcoming World Congress of Nephrology (WCN) in Rio de Janeiro, Brazil 21-25 April will hear about a wide range of study results from Roche's robust renal anaemia clinical trial programs for its two treatments -- MIRCERA(R) and NeoRecormon(R). Among the highlights will be two analyses on MIRCERA, ...
Los Angeles (ots/PRNewswire) - - Lilly Oncology to present more than a dozen studies designed to better predict patient outcomes Delivering on its commitment to relentless progress in cancer care; Lilly Oncology will present 17 studies at the 2007 American Association for Cancer Research (AACR) Annual Meeting in Los Angeles from April 14-18, 2007. Many of ...
Barcelona, Spain (ots/PRNewswire) - - SEBIVO Suppressed Virus More Rapidly and Profoundly Than Adefovir(1) - Rapid and Powerful Viral Suppression Led to Better Treatment Outcomes(2) - SEBIVO Has Been Recommended for Approval by European Medicines Agency, Pending Final Approval by the European ...
Basel, Switzerland (ots/PRNewswire) - - High Response Rates Confirmed in 'Real-Life' Study and Clinical Trials BASEL, Switzerland, April 13 /PRNewswire/ -- Patients with hepatitis C who respond quickly to treatment have an excellent chance of being cured of the disease, according to data presented today ...
Edmonton, Alberta (ots/PRNewswire) - Isotechnika will host an evening educational symposium at the American Transplant Congress. The evening symposium titled "Unleashing the Power of CNi's" will take place on Saturday, May 5th at 7:30 p.m. at the San Francisco Marriott Hotel. The symposium will highlight the use of ISA247 for the prevention of transplant ...
Munich, Germany (ots/PRNewswire) - - The First Rapid Culture-Based Test With Results in Five Hours Clinicians attending the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) learned today that there is a new weapon available in the fight against Methicillin-resistant Staphyloccocus aureus (commonly referred to as MRSA). Hospitals fighting the battle to stop the spread of the ...
Basel, Switzerland (ots/PRNewswire) - - New Oral Treatment Option Reduces Time in Hospital by 80% - For Non-US Media Only The European Commission has approved Xeloda in combination with platinum-based chemotherapy, for first-line use in patients with advanced stomach cancer. Oral chemotherapy Xeloda, is already replacing standard intravenous (i.v.) ...
Edmonton (ots/PRNewswire) - - Company Set to Host Evening Symposium at ATC Isotechnika Inc. announced today that an independent data monitoring committee (DMC) has met and reviewed the interim data from the Phase 2b kidney transplant (PROMISE) trial. The review included 3 month data from approximately ...
London (ots/PRNewswire) - - METEOR Trial Shows CRESTOR Slowed Progression of Atherosclerosis in People at Low-Risk of Coronary Heart Disease (Framingham 10 Year Risk ...
Bristol -Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd
Madrid (ots/PRNewswire) - - New Survey Indicates There is Room for Improvement in Physical Health Management Strategies for People Living With Schizophrenia New data presented at the 15th European Congress of Psychiatry (AEP) indicates that the impact of weight gain and metabolic abnormalities associated ...
London (ots/PRNewswire) - AstraZeneca today announced SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release) clinical trial data presented at the European Congress of Psychiatry (ECP) in Madrid. The data demonstrated that the SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release), administered once daily, ...
Carlsbad, California (ots/PRNewswire) - - Start of Phase 1 Clinical Trial Planned for the Second Half of This Year Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focused on the development of novel and proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, and ...
Carlsbad, California (ots/PRNewswire) - Micromet, Inc. (Nasdaq: MITI) ("Micromet" or the "Company"), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced its financial results for the fourth quarter and the full year ended December 31, 2006. As a ...
Basel, Switzerland (ots/PRNewswire) - - New International Trial Called PROGRESS Starts in 15 Countries Roche today announces the start of a large multinational trial in patients with difficult-to-cure genotype 1 hepatitis C. This international study will evaluate the effect of PEGASYS (peginterferon ...
St. Paul, Minnesota (ots/PRNewswire) - - For the attention of News and Business Editors 3M Health Care announced today the launch of a new Medical Diagnostics business unit that will focus on developing and commercializing rapid diagnostic product solutions for the detection of key infectious pathogens, ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has received approval from United States Adopted Name (USAN) for naming of its lead immunosuppressive drug, ISA247. The name, voclosporin, is now being reviewed by the International Nonproprietary Name (INN) expert committee. The INN is scheduled to publish the proposed list of ...
Basel, Switzerland (ots/PRNewswire) - - New global educational resources spotlight renal anaemia, a common under-recognized complication of Chronic Kidney Disease To help support health professionals who play a key role in educating and managing patients with Chronic Kidney Disease (CKD), Roche today announced the launch of AnaemiaWorld.com, a major new centralized online resource. AnaemiaWorld.com is believed ...
Brussels (ots/PRNewswire) - Ansell Healthcare, a world leader in barrier protection, welcomes the European Commission's recently announced strategy to reduce occupational accidents and diseases in the European Union by 25% by 2012. Ansell Healthcare, a producer of both medical and industrial gloves, claims that ...
Basingstoke, England (ots/PRNewswire) - Clinical Solutions, a leading British provider of software solutions to the healthcare market, has been selected to provide call centre management and clinical decision support software for the Portuguese Public Health System. The software will be used by staff manning Portugal's first national health helpline to record patient calls and provide information to aid advice for ...
Round Lake, Illinois (ots/PRNewswire) - Fenwal Inc. today announced its launch as an independent company. The new corporation is formed upon Baxter Healthcare Corporation completing the sale of its Transfusion Therapies business to Texas Pacific Group (TPG) and Maverick Capital, Ltd. Established by TPG ...
Ottawa, Canada (ots/PRNewswire) - - Expanded Facility in Fleurus, Belgium to be Leading Player in Supply of Glucotrace(R) for Growing Market MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals for molecular imaging, is investing U.S. $5.8 million / (euro) 4.5 million to expand its production facility in Fleurus, Belgium to ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. annual report 28.02.2007 Pfaeffikon SZ, 28 February 2007 --- In the fiscal year ending 31 December 2006 shaPE made further progress as documented by the share price which gained 12% to a record level of CHF 243.00. shaPE achieved a gross ...
Alderley Park, England (ots/PRNewswire) - - A Phase III international, parallel group, randomised, double-blind study of vandetanib in combination with pemetrexed for advanced non-small cell lung cancer (NSCLC) after failure of first line anti-cancer therapy AstraZeneca today announced that a new Phase ...
Indianapolis (ots/PRNewswire) - - Trial will help better identify appropriate patient, define the benefit-risk profile in this population Eli Lilly and Company (NYSE: LLY) today announced plans for a new clinical study of Xigris(R) (drotrecogin alfa [activated]). The trial is designed to help clinicians better identify severe sepsis patients at high risk of death who are more likely to benefit from this ...